Similar articles for PMID: 17942939

Year	Number of Results
1997	1
2000	4
2001	3
2002	4
2003	9
2004	4
2005	2
2006	8
2007	7
2008	8
2009	10
2010	12
2011	8
2012	11
2013	10
2014	7
2015	6
2016	4
2017	2
2018	2
2019	3
2020	1
2021	5
2022	7
2023	1
2024	0

1

Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.

Chang CL, Tsai YC, He L, Wu TC, Hung CF. Chang CL, et al. Cancer Res. 2007 Oct 15;67(20):10047-57. doi: 10.1158/0008-5472.CAN-07-0523. Cancer Res. 2007. PMID: 17942939 Free PMC article.

2

alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors.

Choi YS, Hoory T, Monie A, Wu A, Connolly D, Hung CF. Choi YS, et al. Vaccine. 2008 Oct 29;26(46):5855-63. doi: 10.1016/j.vaccine.2008.08.027. Epub 2008 Sep 2. Vaccine. 2008. PMID: 18771701 Free PMC article.

3

Control of human mesothelin-expressing tumors by DNA vaccines.

Chang CL, Wu TC, Hung CF. Chang CL, et al. Gene Ther. 2007 Aug;14(16):1189-98. doi: 10.1038/sj.gt.3302974. Epub 2007 Jun 21. Gene Ther. 2007. PMID: 17581599 Free PMC article.

4

A novel mycobacterial Hsp70-containing fusion protein targeting mesothelin augments antitumor immunity and prolongs survival in murine models of ovarian cancer and mesothelioma.

Yuan J, Kashiwagi S, Reeves P, Nezivar J, Yang Y, Arrifin NH, Nguyen M, Jean-Mary G, Tong X, Uppal P, Korochkina S, Forbes B, Chen T, Righi E, Bronson R, Chen H, Orsulic S, Brauns T, Leblanc P, Scholler N, Dranoff G, Gelfand J, Poznansky MC. Yuan J, et al. J Hematol Oncol. 2014 Feb 24;7:15. doi: 10.1186/1756-8722-7-15. J Hematol Oncol. 2014. PMID: 24565018 Free PMC article.

5

Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells.

Hung CF, Tsai YC, He L, Wu TC. Hung CF, et al. Gene Ther. 2007 Jun;14(12):921-9. doi: 10.1038/sj.gt.3302913. Epub 2007 Mar 22. Gene Ther. 2007. PMID: 17377599 Free PMC article.

6

Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.

Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Rice CM, Ling M, Wu TC. Cheng WF, et al. J Immunol. 2001 May 15;166(10):6218-26. doi: 10.4049/jimmunol.166.10.6218. J Immunol. 2001. PMID: 11342644

7

Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors.

Kim D, Hoory T, Monie A, Wu A, Hsueh WT, Pai SI, Hung CF. Kim D, et al. J Biomed Sci. 2010 Jul 26;17(1):61. doi: 10.1186/1423-0127-17-61. J Biomed Sci. 2010. PMID: 20659328 Free PMC article.

8

Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes.

Takemoto S, Nishikawa M, Guan X, Ohno Y, Yata T, Takakura Y. Takemoto S, et al. Mol Pharm. 2010 Oct 4;7(5):1715-23. doi: 10.1021/mp1001069. Epub 2010 Sep 3. Mol Pharm. 2010. PMID: 20695521

9

HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice.

Manjili MH, Wang XY, Chen X, Martin T, Repasky EA, Henderson R, Subjeck JR. Manjili MH, et al. J Immunol. 2003 Oct 15;171(8):4054-61. doi: 10.4049/jimmunol.171.8.4054. J Immunol. 2003. PMID: 14530326

10

High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses.

Flechtner JB, Cohane KP, Mehta S, Slusarewicz P, Leonard AK, Barber BH, Levey DL, Andjelic S. Flechtner JB, et al. J Immunol. 2006 Jul 15;177(2):1017-27. doi: 10.4049/jimmunol.177.2.1017. J Immunol. 2006. PMID: 16818758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

125 results

Results by year